We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+4.14%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.1B
AUM Growth
–
Cap. Flow
+$20.8B
Cap. Flow
% of AUM
98.76%
Top 10 Holdings %
Top 10 Hldgs %
26.91%
Holding
1,431
New
1,431
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.1B |
| 2 |
Apple
AAPL
|
+$895M |
| 3 |
Microsoft
MSFT
|
+$781M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$593M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$523M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.88% |
| 2 | Financials | 10.47% |
| 3 | Healthcare | 9.59% |
| 4 | Consumer Discretionary | 7.62% |
| 5 | Industrials | 6.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Hayward Holdings
HAYW
$3.28B
| $13.1M | 0.06% |
+845,975
| New | +$13.4M |
|
277
Travelers Companies
TRV
$82.9B
| $13.1M | 0.06% |
+45,004
| New | +$12.7M |
|
278
iShares Russell 1000 Value ETF
IWD
$82.2B
| $12.8M | 0.06% |
+61,091
| New | +$12.6M |
|
279
Valvoline
VVV
$5.13B
| $12.7M | 0.06% |
+436,116
| New | +$14M |
|
280
New Jersey Resources
NJR
$6.04B
| $12.7M | 0.06% |
+274,626
| New | +$12.7M |
|
281
ICU Medical
ICUI
$4.14B
| $12.6M | 0.06% |
+88,294
| New | +$11.8M |
|
282
LCI Industries
LCII
$2.62B
| $12.5M | 0.06% |
+103,276
| New | +$11M |
|
283
Energy Transfer Partners
ET
$69.5B
| $12.5M | 0.06% |
+759,556
| New | +$12.6M |
|
|
MRX
284
Marex Group Limited Ordinary Shares
MRX
$4.62B
| $12.5M | 0.06% |
+326,415
| New | +$11.1M |
|
285
Altria Group
MO
$125B
| $12.4M | 0.06% |
+215,541
| New | +$13M |
|
286
Ashland
ASH
$3.11B
| $12.2M | 0.06% |
+208,755
| New | +$11M |
|
287
CNX Resources
CNX
$4.84B
| $12.2M | 0.06% |
+331,612
| New | +$11.9M |
|
288
BorgWarner
BWA
$13B
| $12.2M | 0.06% |
+269,826
| New | +$11.8M |
|
289
Acadia Pharmaceuticals
ACAD
$4.45B
| $12.1M | 0.06% |
+453,643
| New | +$10.8M |
|
290
Idexx Laboratories
IDXX
$44.9B
| $12.1M | 0.06% |
+17,901
| New | +$12.2M |
|
291
Evercore
EVR
$13.2B
| $12M | 0.06% |
+35,214
| New | +$11.3M |
|
292
Supernus Pharmaceuticals
SUPN
$2.77B
| $11.9M | 0.06% |
+239,183
| New | +$11.6M |
|
293
Lockheed Martin
LMT
$134B
| $11.9M | 0.06% |
+24,566
| New | +$11.8M |
|
294
Kroger
KR
$36.3B
| $11.8M | 0.06% |
+189,465
| New | +$12.4M |
|
|
PDM
295
Piedmont Realty Trust
PDM
$1.2B
| $11.8M | 0.06% |
+1,410,834
| New | +$11.8M |
|
296
Amdocs
DOX
$5.83B
| $11.8M | 0.06% |
+146,031
| New | +$11.7M |
|
297
Grocery Outlet
GO
$902M
| $11.7M | 0.06% |
+1,161,322
| New | +$14.6M |
|
298
Fidelity National Information Services
FIS
$23.2B
| $11.7M | 0.06% |
+175,607
| New | +$11.6M |
|
299
Expeditors International
EXPD
$22.4B
| $11.7M | 0.06% |
+78,214
| New | +$10.6M |
|
300
Progress Software
PRGS
$1.66B
| $11.6M | 0.06% |
+270,682
| New | +$11.8M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q4 2025 Portfolio in Review
Q4 2025 is the first quarter with a 13F filing on record for Glenmede Trust, which disclosed 1,431 positions worth $21.1B. Its ten largest holdings account for 27% of the portfolio.
Its largest position is Vanguard S&P 500 ETF: 1,772,161 shares worth $1.11B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, followed by Financials and Healthcare.
- Glenmede Trust's largest Q4 2025 buy was Vanguard S&P 500 ETF: 1,772,161 shares worth $1.11B.
- Glenmede Trust's ten largest holdings make up 27% of its $21.1B portfolio in Q4 2025.
- Glenmede Trust disclosed 1,431 positions in Q4 2025, its first 13F filing on record.
Based on Glenmede Trust's 13F filing for Q4 2025, filed 17 Feb 2026.